4//SEC Filing
Kite Pharma, Inc. 4
Accession 0001209191-17-039021
CIK 0001510580operating
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 9:11 PM ET
Size
7.0 KB
Accession
0001209191-17-039021
Insider Transaction Report
Form 4
DOUMANI ROY
Director
Transactions
- Sale
Common Stock
2017-06-07$84.46/sh−10,000$844,621→ 155,017 total - Sale
Common Stock
2017-06-08$84.53/sh−5,000$422,634→ 150,017 total
Holdings
- 25,065(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.265 to $85.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Kite Pharma, Inc.
CIK 0001510580
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001510580
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 9:11 PM ET
- Size
- 7.0 KB